# PhenixFIN Corp: financial statements, quarterly

PFX · Nasdaq · CIK 1490349 · [Other](/sectors/other.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/pfx.md) · [Financials](/companies/pfx/financials.md) · [Filings](/companies/pfx/filings.md) · [Insiders](/companies/pfx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pfx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [1,502 d](/filings/0001213900-25-120913.md) | [1,542](/filings/0001213900-25-011052.md) | [1,567](/filings/0001213900-25-040261.md) | [1,722](/filings/0001213900-25-072562.md) | [1,778 d](/filings/0001213900-25-120913.md) | [2,546](/filings/0001213900-26-013689.md) | [2,579](/filings/0001213900-26-052253.md) | [2,660](/filings/0001213900-26-085667.md) | [2,494 d](/filings/0001213900-25-120913.md) | [2,432](/filings/0001213900-26-013689.md) | [2,309](/filings/0001213900-26-052253.md) | [2,320](/filings/0001213900-26-085667.md) |
| Net income | $k | [7,342 d](/filings/0001213900-25-120913.md) | [4,534](/filings/0001213900-25-011052.md) | [5,372](/filings/0001213900-25-040261.md) | [2,609](/filings/0001213900-25-072562.md) | [6,104 d](/filings/0001213900-25-120913.md) | [2,464](/filings/0001213900-26-013689.md) | [(896)](/filings/0001213900-26-052253.md) | [(1,497)](/filings/0001213900-26-085667.md) | [4,085 d](/filings/0001213900-25-120913.md) | [(4,770)](/filings/0001213900-26-013689.md) | [1,133](/filings/0001213900-26-052253.md) | [4,224](/filings/0001213900-26-085667.md) |
| Diluted EPS | $ per share | not reported | [2.19](/filings/0001213900-25-011052.md) | [2.62](/filings/0001213900-25-040261.md) | [1.29](/filings/0001213900-25-072562.md) | not reported | [1.22](/filings/0001213900-26-013689.md) | [(0.44)](/filings/0001213900-26-052253.md) | [(0.74)](/filings/0001213900-26-085667.md) | not reported | [(2.38)](/filings/0001213900-26-013689.md) | [0.57](/filings/0001213900-26-052253.md) | [2.19](/filings/0001213900-26-085667.md) |
| Basic EPS | $ per share | not reported | [2.19](/filings/0001213900-25-011052.md) | [2.62](/filings/0001213900-25-040261.md) | [1.29](/filings/0001213900-25-072562.md) | not reported | [1.22](/filings/0001213900-26-013689.md) | [(0.44)](/filings/0001213900-26-052253.md) | [(0.74)](/filings/0001213900-26-085667.md) | not reported | [(2.38)](/filings/0001213900-26-013689.md) | [0.57](/filings/0001213900-26-052253.md) | [2.19](/filings/0001213900-26-085667.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.0](/filings/0001213900-24-109444.md) | [12.2](/filings/0001213900-24-011611.md) | [19.1](/filings/0001213900-24-041496.md) | [8.9](/filings/0001213900-24-065749.md) | [67.6](/filings/0001213900-25-120913.md) | [7.2](/filings/0001213900-25-011052.md) | [8.7](/filings/0001213900-25-040261.md) | [7.3](/filings/0001213900-25-072562.md) | [7.3](/filings/0001213900-26-085667.md) | [3.4](/filings/0001213900-26-013689.md) | [3.1](/filings/0001213900-26-052253.md) | [2.2](/filings/0001213900-26-085667.md) |
| Total assets | $m | [240](/filings/0001213900-24-109444.md) | [238](/filings/0001213900-24-011611.md) | [248](/filings/0001213900-24-041496.md) | [246](/filings/0001213900-24-065749.md) | [303](/filings/0001213900-25-120913.md) | [312](/filings/0001213900-25-011052.md) | [301](/filings/0001213900-25-040261.md) | [307](/filings/0001213900-25-072562.md) | [317](/filings/0001213900-26-085667.md) | [307](/filings/0001213900-26-013689.md) | [306](/filings/0001213900-26-052253.md) | [310](/filings/0001213900-26-085667.md) |
| Total liabilities | $m | [93.0](/filings/0001213900-24-109444.md) | [87.1](/filings/0001213900-24-011611.md) | [93.4](/filings/0001213900-24-041496.md) | [92.1](/filings/0001213900-24-065749.md) | [142](/filings/0001213900-25-120913.md) | [149](/filings/0001213900-25-011052.md) | [142](/filings/0001213900-25-040261.md) | [150](/filings/0001213900-25-072562.md) | [156](/filings/0001213900-26-085667.md) | [152](/filings/0001213900-26-013689.md) | [152](/filings/0001213900-26-052253.md) | [152](/filings/0001213900-26-085667.md) |
| Shareholders' equity | $m | [147](/filings/0001213900-25-120913.md) | [151](/filings/0001213900-25-040261.md) | [154](/filings/0001213900-25-072562.md) | [154](/filings/0001213900-25-072562.md) | [160](/filings/0001213900-26-085667.md) | [163](/filings/0001213900-26-052253.md) | [159](/filings/0001213900-26-085667.md) | [157](/filings/0001213900-26-085667.md) | [161](/filings/0001213900-26-085667.md) | [156](/filings/0001213900-26-052253.md) | [154](/filings/0001213900-26-085667.md) | [158](/filings/0001213900-26-085667.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.5) d](/filings/0001213900-25-120913.md) | [6.8](/filings/0001213900-25-011052.md) | [9.0 d](/filings/0001213900-25-040261.md) | [(8.3) d](/filings/0001213900-25-072562.md) | [8.7 d](/filings/0001213900-25-120913.md) | [(66.3)](/filings/0001213900-26-013689.md) | [8.8 d](/filings/0001213900-26-052253.md) | [(6.9) d](/filings/0001213900-26-085667.md) | [(3.0) d](/filings/0001213900-25-120913.md) | [(2.0)](/filings/0001213900-26-013689.md) | [2.7 d](/filings/0001213900-26-052253.md) | [(0.7) d](/filings/0001213900-26-085667.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001213900-25-120913.md) | not reported | not reported | [0.0 d](/filings/0001213900-26-085667.md) | [0.0 d](/filings/0001213900-25-120913.md) | not reported | not reported | not reported |
| Share repurchases | $m | [0.6 d](/filings/0001213900-25-120913.md) | [0.5](/filings/0001213900-25-011052.md) | [1.8 d](/filings/0001213900-25-040261.md) | [0.0 d](/filings/0001213900-25-072562.md) | [0.0 d](/filings/0001213900-25-120913.md) | not reported | not reported | not reported | [0.0 d](/filings/0001213900-25-120913.md) | [0.2](/filings/0001213900-26-013689.md) | [3.1 d](/filings/0001213900-26-052253.md) | [0.0 d](/filings/0001213900-26-085667.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,101](/filings/0001213900-24-011611.md) | [2,095](/filings/0001213900-24-041496.md) | [2,091](/filings/0001213900-24-065749.md) | [2,073](/filings/0001213900-25-011052.md) | [2,049](/filings/0001213900-25-040261.md) | [2,020](/filings/0001213900-25-072562.md) | [2,020](/filings/0001213900-26-013689.md) | [2,020](/filings/0001213900-26-052253.md) | [2,017](/filings/0001213900-26-085667.md) | [2,001](/filings/0001213900-26-013689.md) | [1,973](/filings/0001213900-26-052253.md) | [1,933](/filings/0001213900-26-085667.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,931,273 at 2026-08-05, from the cover of the [10-Q filed 2026-08-05](/filings/0001213900-26-085667.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.